Retrospective analysis of clinical and cost outcomes associated with methicillin-resistant Staphylococcus aureus complicated skin and skin structure infections treated with daptomycin, vancomycin, or linezolid
Wright BM, Eiland EH
 
 
Record Status
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Bibliographic details
Wright BM, Eiland EH. Retrospective analysis of clinical and cost outcomes associated with methicillin-resistant Staphylococcus aureus complicated skin and skin structure infections treated with daptomycin, vancomycin, or linezolid. Journal of Pathogens 2011; 2011:347969
PubMedID
22567330
DOI
10.4061/2011/347969
Original Paper URL
http://www.hindawi.com/journals/jpath/2011/347969/abs/
Indexing Status
Subject indexing assigned by CRD
MeSH
Acetamides; Anti-Infective Agents; Cost-Benefit Analysis; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin
AccessionNumber
22012041633
Date bibliographic record published
15/02/2013
 
NHS Economic Evaluation Database (NHS EED)
Produced by the Centre for Reviews and Dissemination
Copyright © 2025 University of York
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for NHS EED database users